Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth

Thursday, February 03, 2022

Vericel Corporation a leader in advanced therapies for the sports medicine and severe burn care markets today announced that it has entered into a longterm lease agreement for a new stateoftheart advanced cell therapy manufacturing and corporate head...

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

Wednesday, February 02, 2022

German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA Darmstadt Germany in the research project RNA Splicing in Cancer RSC As a result of the successful research work to date Merck KGaA Darm...

Coriolis Pharma Opens New ATMP Formulation Development Facilities

Wednesday, February 02, 2022

Coriolis Pharma a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines today announced the opening of its new ATMP development facilities under biosafety level S B...

Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients

Tuesday, February 01, 2022

Leica Biosystems a cancer diagnostics company has entered into an agreement with Leap Therapeutics NASDAQ LPTX a biotechnology company to develop a companion diagnostic to detect Dickkopfrelated protein DKK The assay will be used to support clinical...

Oxford Biomedica announces that Sio Gene Therapies intends to cease the license agreement for gene therapy programme in Parkinson’s disease

Tuesday, February 01, 2022

Oxford Biomedica plc a leading gene and cell therapy group announced today that it was informed on Monday January by Sio Gene Therapies Sio that Sio intends to return the global rights for AXOLentiPD and that they intend to cease work on this gene t...

European Commission approves Teysuno in metastatic colorectal cancer

Monday, January 31, 2022

Nordic Pharma announces that on the th of January the European Commission EC approved the new indication for Teysuno tegafurgimeraciloteracil for the treatment of patients with metastatic colorectal cancer who cannot continue fluoropyrimidine treatme...

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate

Friday, January 28, 2022

HaemaLogiX Ltd HaemaLogiX the clinicalstage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma and Lonza a global development and manufacturing partner to the pharma biotech and nutrition industries have entered...

Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment

Friday, January 28, 2022

Pfizer Inc announced today that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA issued a positive opinion recommending the conditional marketing authorization CMA of Pfizers PAXLOVID nirmatrelvir PF tablet...

Atara Biotherapeutics Enters Strategic Manufacturing Partnership with Fujifilm

Thursday, January 27, 2022

Atara Biotherapeutics Inc a leader in Tcell immunotherapy leveraging its novel allogeneic EBV Tcell platform to develop transformative therapies for patients with cancer and autoimmune diseases today announced that it has entered into a long term str...

Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran

Thursday, January 27, 2022

Polydex Pharmaceuticals Limited is pleased to announce that it has entered into an agreement with Termanox Water Treatment Solutions for a novel use of its native dextran product Termanox a Dutch company has developed and patented a cooling water tre...